151 related articles for article (PubMed ID: 20087232)
1. Pelvic sentinel lymph node biopsy in melanoma patients: is it worthwhile?
Soteldo J; Ratto EL; Gandini S; Trifirò G; Mazzarol G; Tosti G; Rastrelli M; Verrecchia F; Baldini F; Testori A
Melanoma Res; 2010 Apr; 20(2):133-7. PubMed ID: 20087232
[TBL] [Abstract][Full Text] [Related]
2. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.
Gipponi M; Di Somma C; Peressini A; Solari N; Gliori S; Nicolo G; Schenone F; Queirolo P; Sertoli MR; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):133-40. PubMed ID: 14991885
[TBL] [Abstract][Full Text] [Related]
4. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
[TBL] [Abstract][Full Text] [Related]
5. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin.
Allan CP; Hayes AJ; Thomas JM
ANZ J Surg; 2008 Nov; 78(11):982-6. PubMed ID: 18959697
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
7. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
Essner R; Scheri R; Kavanagh M; Torisu-Itakura H; Wanek LA; Morton DL
Arch Surg; 2006 Sep; 141(9):877-82; discussion 882-4. PubMed ID: 16983031
[TBL] [Abstract][Full Text] [Related]
9. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.
Gipponi M
Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921
[TBL] [Abstract][Full Text] [Related]
10. Is the node of Cloquet the sentinel node for the iliac/obturator node group?
Shen P; Conforti AM; Essner R; Cochran AJ; Turner RR; Morton DL
Cancer J; 2000; 6(2):93-7. PubMed ID: 11069226
[TBL] [Abstract][Full Text] [Related]
11. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.
Badgwell B; Xing Y; Gershenwald JE; Lee JE; Mansfield PF; Ross MI; Cormier JN
Ann Surg Oncol; 2007 Oct; 14(10):2867-75. PubMed ID: 17671814
[TBL] [Abstract][Full Text] [Related]
12. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.
van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM
Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089
[TBL] [Abstract][Full Text] [Related]
13. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.
Scheri RP; Essner R; Turner RR; Ye X; Morton DL
Ann Surg Oncol; 2007 Oct; 14(10):2861-6. PubMed ID: 17882497
[TBL] [Abstract][Full Text] [Related]
14. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy in head and neck squamous cell carcinoma.
Pitman KT; Johnson JT; Brown ML; Myers EN
Laryngoscope; 2002 Dec; 112(12):2101-13. PubMed ID: 12461328
[TBL] [Abstract][Full Text] [Related]
16. The role of sentinel lymph node biopsy in patients with local recurrence or in-transit metastasis of melanoma.
Gipponi M; Solari N; Giovinazzo D; Queirolo P; Bertoglio S; Villa G; Gualco M; Bleidl D; Cafiero F
Anticancer Res; 2014 Jun; 34(6):3197-203. PubMed ID: 24922694
[TBL] [Abstract][Full Text] [Related]
17. Vulvar melanoma: is there a role for sentinel lymph node biopsy?
de Hullu JA; Hollema H; Hoekstra HJ; Piers DA; Mourits MJ; Aalders JG; van der Zee AG
Cancer; 2002 Jan; 94(2):486-91. PubMed ID: 11905414
[TBL] [Abstract][Full Text] [Related]
18. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
[TBL] [Abstract][Full Text] [Related]
19. The prognostic role of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma: experience of the Genoa group.
Gipponi M; Solari N; Lionetto R; Di Somma C; Villa G; Schenone F; Queirolo P; Cafiero F
Eur J Surg Oncol; 2005 Dec; 31(10):1191-7. PubMed ID: 15894454
[TBL] [Abstract][Full Text] [Related]
20. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
